THE LIDC AND ITS MISSION
The LIDC is a Consortium of 5 Institutions funded by the National Cancer Institute under the Cancer Imaging Program (CIP). These institutions are:
Members of other institutions also participate in key roles such as statistical design.
MISSION
The mission of the LIDC is the sharing of lung images, especially low-dose helical CT scans of adults screened for lung cancer, and related technical and clinical data for the development and testing of computer-aided diagnosis (CAD) technologies.
PRINCIPAL GOALS
To establish standard formats and processes for managing thoracic CT scans and related technical and clinical data for use in the development and testing of CAD algorithms.
To develop an image database as a web-accessible international research resource for the development, training, and evaluation of CAD methods for lung cancer detection and diagnosis using helical CT.
CHALLENGES IN CONSTRUCTING THE DATABASE
| VISIT THIS EXHIBIT FOR CME CATEGORY 1 CREDIT MONDAY THRU THURSDAY 12:15 pm to 1:15 pm At that time, LIDC members will be here to describe
|
DATABASE IMPLEMENTATION STEPS
TASKS COMPLETED (see current reports on website):TASKS ONGOING (expected completion date):
IMPLEMENTATION TIMELINE
| Task | Date Expected |
|---|---|
| Specify Complete Data Model | Jan 04 |
| Specify LIDC internal workflow | |
| Data passing, Performing reviews | Jan 04 |
| Initial implementation, testing of workflow | Jan/Feb 04 |
| Database Implementation- Start | Jan 04 |
| Database Implementation- Completion | Mar/Apr 04 |
| Implementing Public Interface to Database | Apr/May 04 |
| PUBLIC ACCESS TO CASES - EXPECTED | MAY/JUN 04 |
LIDC WEBSITE
Overview - www3.cancer.gov/bip/steer_lidc.htm
Committee Reports - www3.cancer.gov/bip/lidc_comm.htm
Contains publicly available documents describing inclusion criteria, process model details, etc.
AUTHORS
Samuel G. Armato III, PhD1, Laurence P. Clarke, PhD2, Geoffrey McLennan, MD3, Michael F. McNitt-Gray, PhD4 , Chuck R. Meyer, PhD5, David Yankelevitz, MD6, Denise R. Aberle, MD4, Barbara Y. Croft, PhD2, Claudia I. Henschke, MD, PhD6, Eric A. Hoffman, PhD3, Ella A. Kazerooni, MD5, Heber MacMahon, MD1, Anthony P. Reeves, PhD6 , Nicholas Petrick, PhD7, Robert Wagner, PhD7, David Gur, PhD8, Lori Dodd, PhD2, Carl Jaffe, MD2, Peyton H. Bland, PhD5, Keith Brautigam, BA3, Matthew S. Brown, PhD4, Barry De Young, MD3, Roger Engelmann, MS1, Andinet Enquobahrie, MS6, Carey E. Floyd, Jr., PhD9, Junfeng Guo, PhD3, Aliya Husain, MD1, Gary Laderach5, Charles E. Metz, PhD1, Brian Mullan, MD3, Richard Pais, BS4, Christopher Piker, BS3, James Sayre, DrPH4 , Adam Starkey1 1Department of Radiology, University of Chicago, 2Cancer Imaging Program, National Cancer Institute, 3 University of Iowa Roy J. and Lucille A. Carver School of Medicine, 4 David Geffen School of Medicine, University of California, Los Angeles, 5Department of Radiology, University of Michigan Medical School, 6Weill Medical College of Cornell University, 7U.S. Food and Drug Administration, 8Department of Radiology, University of Pittsburgh, 9Department of Radiology, Duke University
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®